Rfp Financial Group LLC Bio N Tech Se Transaction History

Rfp Financial Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$80.36 - $102.87 $2,250 - $2,880	-28 Reduced 51.85%	26 $2,000
Q1 2024 May 09, 2024	BUY	$88.96 - $112.35 $2,490 - $3,145	28 Added 107.69%	54 $4,000
Q4 2023 Feb 12, 2024	SELL	$90.91 - $112.75 $1,454 - $1,804	-16 Reduced 38.1%	26 $2,000
Q4 2022 Jan 24, 2023	BUY	$118.43 - $186.05 $4,974 - $7,814	42 New	42 $6.31 Million

323

38.9M

845K

1.28M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Rfp Financial Group LLC with notifications on news.